NOTES PAYABLE (Details Narrative) - USD ($) |
9 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2025 |
Feb. 07, 2025 |
Feb. 28, 2025 |
Feb. 29, 2024 |
Feb. 28, 2024 |
Jan. 06, 2025 |
Dec. 30, 2024 |
Dec. 18, 2024 |
Dec. 12, 2024 |
Nov. 27, 2024 |
Nov. 19, 2024 |
May 31, 2024 |
|
| Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
| Amortization of debt discounts | $ 85,106 | |||||||||||
| Share issued, value | 548,750 | |||||||||||
| Restricted cash | $ 250,000 | 250,000 | ||||||||||
| Interest expenses | $ 5,719 | $ 0 | ||||||||||
| 5 Accredited Investors [Member] | ||||||||||||
| Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
| Share issued, value | 10.00% | 10.00% | ||||||||||
| Principal amount | $ 10,000 | $ 10,000 | $ 10,000 | $ 25,000 | ||||||||
| Debt Instrument, Issuer | The Company agreed to issue to each of these investors as inducement restricted shares of the Company’s common stock equal to 1.5 shares for each dollar of the principal amount of the Note | |||||||||||
| Stock Issued During Period, Shares, New Issues | 97,500 | |||||||||||
| Notes payable amount | $ 48,750 | $ 48,750 | ||||||||||
| Conversion price | $ 0.50 | $ 0.50 | ||||||||||
| Share price | $ 2 | $ 2 | ||||||||||
| Share issued | 1,000,000 | 1,000,000 | ||||||||||
| Share issued, value | $ 250,000 | $ 500,000 | ||||||||||
| Restricted cash | $ 250,000 | $ 250,000 | ||||||||||
| Single Accredited Investor [Member] | ||||||||||||
| Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
| Principal amount | $ 300,000 | $ 100,000 | $ 100,000 | |||||||||
| Stock Issued During Period, Shares, New Issues | 1,000,000 | |||||||||||
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Identification of the contractual issuer of the debt instrument (for example, a subsidiary of the reporting entity). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fair value of stock issued in noncash financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|